STAT - Reporting from the frontiers of health and medicine

The Readout LOUD

Special Report

Health

Politics Pelosi: Democrats will name marquee drug pricing bill for late Rep. Cummings
Biotech These four companies are betting big on CBD-based prescription drugs
In the Lab Doctors argue for term limits to diversify medical school leadership
Biotech Sean Parker, billionaire and philanthropist, gets an immunotherapy company off the ground
First Opinion As the need for organ transplants grows, the number of transplant physicians dwindles

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

CSL sues a former employee and rival over alleged theft of trade secrets
Most state Medicaid programs continue to restrict access to hepatitis C medicines
Pharmalittle: Five companies offer $50 billion deal to settle opioid suits; FDA approves record number of generics

Health

Health

Health

By Brittany Flaherty

First Opinion

Special Report

First Opinion

By Dorothy Pomerantz

In the Lab Here’s a brain teaser: Surprising study shows reduced neuronal activity extends life
Special Report Forecasting Alzheimer’s: With a tsunami of new diagnoses expected, experts calculate the best ways to shift the tide
In the Lab Doctors argue for term limits to diversify medical school leadership
Health Competitor accuses 23andMe of ‘false negatives’ in cancer-gene testing
Biotech Sean Parker, billionaire and philanthropist, gets an immunotherapy company off the ground